Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 4, 2011, Pages 1039-1045

  Ahmed, Ashraf H ^a   Calvird, Michele ^b   Gordon, Richard D ^a   Taylor, Paul J ^a   Ward, Gregory ^c   Pimenta, Eduardo ^a   Young, Ross ^d   Stowasser, Michael ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Department of Obstetrics and Gynecology   (Australia)

^c SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CREATININE; ELECTROLYTE; ESCITALOPRAM; HYDROCORTISONE; RENIN; SERTRALINE;

ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE URINE LEVEL; HUMAN; HYDROCORTISONE URINE LEVEL; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION;

ADULT; ALDOSTERONE; ANTIDEPRESSIVE AGENTS; BLOOD PRESSURE; CITALOPRAM; DEPRESSION; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; MALE; RENIN; RENIN-ANGIOTENSIN SYSTEM; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TIME FACTORS;

EID: 79953901454     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2603     Document Type: Article

References (53)

1. Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N, Slater GJ 2001 Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2:156-169 (Pubitemid 33685887)
2. Stowasser M., Gordon RD 2004 The aldosterone-renin ratio in screening for primary aldosteronism. Endocrinologist 14:267-276 (Pubitemid 39232121)
3. Sazbo B, SchultheissA1990 Desipramine inhibits sympathetic nerve activity in the rabbit. Naunyn Schmiedebergs Arch Pharmacol 342: 469-476 (Pubitemid 20284132)
4. Lavian G, Di Bona G, Finberg JP 1991 Inhibition of sympathetic nerve activity by acute administration of the tricyclic antidepressant desipramine. Eur J Pharmacol 194:153-159
5. Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, Jennings G 1991 Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol 260:R817-R823
6. Haynes WG, Egri Z 2005 Sibutramine and the sympathetic nervous system in obese humans. Clin Auton Res 15:189-192 (Pubitemid 40909706)
7. Veith RC, Raskind MA, Barnes RF, Gumbrecht G, Ritchie JL, Halter JB 1983 Tricyclic antidepressants and supine, standing, and exercise plasma norepinephrine levels. Clin Pharmacol Ther 33:763-769 (Pubitemid 13065364)
8. Dronjak S, Spasojevic N, Gavrilovic L, Varagic V 2007 Effects of noradrenaline and serotonin reuptake inhibitors on pituitary-adrenocortical and sympatho-adrenomedullar system of adult rats. Neuro Endocrinol Lett 28:614-620
9. Agelink MW, Ullrich H, Baumann B, Strum S, Majewski T 2002 Effects of reboxetine, a selective norepinephrine reuptake inhibitor, on sympathetic and parasympathetic outflow to the heart: Preliminary data. Psychopharmacology (Berl) 163:151-156 (Pubitemid 35013606)
10. Siepmann T, Ziemssen T, Mueck-Weymann M, Kirch W, Siepmann M 2007 The effects of venlafaxine on autonomic functions in healthy volunteers. J Clin Psychopharmacol 27:687-691 (Pubitemid 351339458)
11. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, Socratous F, KayeDM,SchlaichMP,Hickie I, Lambert GW 2007 Sympathetic activity in major depressive disorder: Identifying those at increased cardiac risk? J Hypertens 25:2117-2124 (Pubitemid 47476310)
12. Scalco AZ, Rondon MU, Trombetta IC, Laterza MC, Azul JB, Pullenayegum EM, Scalco MZ, Kuniyoshi FH, Wajngarten M, Negrão CE, Lotufo-Neto F 2009 Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline. J Hypertens 27:2429-2436
13. Vander AJ 1965 Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs. Am J Physiol 209:659-662
14. Vandongen R, Peart WS, Boyd GW 1973 Andrenergic stimulation of renin secretion in the isolated perfused rat kidney. Circ Res 32: 290-296
15. Ahrens T, Frankhauser P, Lederbogen F, DeuschleM2007 Effect of single-dose sertraline on the hypothalamus-pituitary-adrenal system, autonomic nervous system, and platelet function. J Clin Psychopharmacol 27:602-606 (Pubitemid 351339447)
16. Jongsma ME, Bosker FJ, Cremers TI, Westerink BH, den Boer JA 2005 The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin1Breceptor sensitivity andHPAaxis activity. Prog Neuropsychopharmacol Biol Psychiatry 29:738-744 (Pubitemid 40897785)
17. Golden RN, Hsiao J, Lane E, Hicks R, Rogers S, Potter WZ 1989 The effects of intravenous clomipramine on neurohormones in normal subjects. J Clin Endocrinol Metab 68:632-637 (Pubitemid 19081440)
18. Jezová D, Duncko R 2002 Enhancement of stress-induced pituitary hormone release and cardiovascular activation by antidepressant treatment in healthy men. J Psychopharmacol 16:235-240 (Pubitemid 34983079)
19. Himmerich H, Zimmermann P, Ising M, Kloiber S, Lucae S, Kunzel HE, Binder EB, Holsboer F, Uhr M 2007 Changes in the hypothalamic- pituitary-adrenal axis and leptin levels during antidepressant treatment. Neuropsychobiology 55:28-35 (Pubitemid 47000395)
20. Mason BL, ParianteCM2006 The effects of antidepressants on the hypothalamic-pituitary-adrenal axis. Drug News Perspect 19:603-608 (Pubitemid 46813847)
21. Schüle C 2007 Neuroendocrinological mechanisms of actions of antidepressant drugs. J Neuroendocrinol 19:213-226 (Pubitemid 46210949)
22. den Boer JA, Westenberg HG 1990 Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder. Psychiatry Res 31:267-278 (Pubitemid 20102375)
23. Laakmann G, Wittmann M, Gugath M, Mueller OA, Treusch J, Wahlster U, Stalla GK 1984 Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis. Psychopharmacology (Berl) 84:66-70 (Pubitemid 14032211)
24. Schüle C, Baghai T, Schmidbauer S, Bidlingmaier M, Strasburger CJ, Laakmann G 2004 Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects. Psychoneuroendocrinology 29:185-200 (Pubitemid 37357178)
25. Schüle C, Baghai T, Goy J, Bidlingmaier M, Strasburger C, Laakmann G 2002 The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects. Psychopharmacology (Berl) 163:95-101 (Pubitemid 34985317)
26. Horstmann S, Dose T, Lucae S, Kloiber S, Menke A, Hennings J, Spieler D, Uhr M, Holsboer F, Ising M 2009 Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action. Psychoneuroendocrinology 34:238-248
27. Schüle C, Baghai T, Zwanzger P, Ella R, Eser D, Padberg F, Möller HJ, Rupprecht R 2003 Attenuation of hypothalamic-pituitary- adrenocortical hyperactivity in depressed patients by mirtazapine. Psychopharmacology (Berl) 166:271-275 (Pubitemid 36384774)
28. Inder WJ, Prickett TC, Mulder RT, Donald RA, Joyce PR 2001 Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology (Berl) 156:73-78 (Pubitemid 32646327)
29. Kathol RG, Jaeckle R, Wysham C, Sherman BM 1992 Imipramine effect on hypothalamic-pituitary-adrenal axis response to hypoglycemia. Psychiatry Res 41:45-52
30. Lee MS, Yang JW, Ko YH, Han C, Kim SH, Lee MS, Joe SH, Jung IK 2008 Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder. Child Psychiatry Hum Dev 39:201-209 (Pubitemid 351347942)
31. Michelson D, Galliven E, Hill L, Demitrack M, Chrousos G, Gold P 1997 Chronic imipramine is associated with diminished hypotha- lamic-pituitary- adrenal axis responsivity in healthy humans. J Clin Endocrinol Metab 82:2601-2606 (Pubitemid 27337880)
32. Ahmed AH, Gordon RD, Taylor PJ, Ward G, Pimenta E, Stowasser M 2011 Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men? J Clin Endocrinol Metab 96:E340-E346
33. Taylor PJ, Cooper DP, Gordon RD, Stowasser M 2009 Measurement of aldosterone in human plasma by semiautomated HPLCtandem mass spectrometry. Clin Chem 55:1155-1162
34. Crawford JR, Henry JD 2003 The Depression Anxiety Stress Scales (DASS): Normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 42:111-131 (Pubitemid 36781039)
35. Ahmed AH, Gordon RD, Taylor P, Ward G, Pimenta E, Stowasser M 2010 Effect of atenolol on aldosterone/renin ratio calculated by both plasma renin activity and direct renin concentration in healthy male volunteers. J Clin Endocrinol Metab 95:3201-3206
36. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F 2002 Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40:897-902 (Pubitemid 35434913)
37. Seifarth C, Trenkel S, Schobel H,HahnEG, Hensen J 2002 Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol (Oxf) 57:457-465 (Pubitemid 35221345)
38. Vande KarLD1991 Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu Rev Pharmacol Toxicol 31:289-320
39. Epstein S, Hamilton S 1977 Cyproheptadine inhibition of stimulated plasma renin activity. J Clin Endocrinol Metab 45:1235-1237 (Pubitemid 8253451)
40. Shenker Y, Gross MD, Grekin RJ 1985 Central serotonergic stimulation of aldosterone secretion. J Clin Invest 76:1485-1490 (Pubitemid 16193698)
41. Maestri E, Camellini L, Rossi G, Rossi GP, Dotti C, Marchesi M, Gnudi A 1988 Serotonin regulation of aldosterone secretion. Horm Metab Res 20:457-459
42. Oelkers W 1996 Adrenal insufficiency. N Engl J Med 335:1206-1212
43. Melby JC 1971 Assessment of adrenocortical function. N Engl J Med 285:735-739
44. Davis JO 1973 The control of renin release. Am J Med 55:333-350
45. de Magalhães-Nunes AP, Badaueê-Passos Jr D, Ventura RR, Guedes Dda Jr S, Araújo JP, Granadeiro PC, Milanez-Barbosa HK, da Costa-e-Sousa RH, de Medeiros MA, Antunes-Rodrigues J, Reis LC 2007 Sertraline, a selective serotonin reuptake inhibitor, affects thirst, salt appetite and plasma levels of oxytocin and vasopressin in rats. Exp Physiol 92:913-922 (Pubitemid 47283906)
46. Spigset O, Hedenmalm K 1997 Hyponatremia in relation to treatment with antidepressants: A survey of reports in the World Health Organization database for spontaneous reporting of adverse drug reactions. Pharmacotherapy 17:348-352 (Pubitemid 27133361)
47. Stovall R, Brahm NC, Crosby KM 2009 Recurrent episodes of serotonin- reuptake inhibitor-mediated hyponatremia in an elderly patient. Consult Pharm 24:765-768
48. TaylorD2008 Antidepressant drugs and cardiovascular pathology: A clinical overview of effectiveness and safety. Acta Psychiatr Scand 118:434-442
49. Murck H, Held K, Ziegenbein M, Kunzel H, Koch K, SteigerA2003 The renin-angiotensin-aldosterone system in patients with depression compared to controls-a sleep endocrine study. BMC Psychiatry 3:15
50. Emanuele E, Geroldi D, Minoretti P, Coen E, Politi P 2005 Increased plasma aldosterone in patients with clinical depression. Arch Med Res 36:544-548 (Pubitemid 41140063)
51. Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M, Bidlingmaier M 2006 Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: Comparison to radioimmunoassays with and without extraction steps. Clin Chem 52: 1749-1755 (Pubitemid 44330710)
52. Katz FH, Romfh P 1972 Plasma aldosterone and renin activity during the menstrual cycle. J Clin Endocrinol Metab 34:819-821
53. Chidambaram M, Duncan JA, Lai VS, Cattran DC, Floras JS, Scholey JW, Miller JA 2002 Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol 13: 446-452 (Pubitemid 34106287)